Clinical Trials
4
Active:0
Completed:4
Trial Phases
3 Phases
Phase 1:2
Phase 2:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (50.0%)Not Applicable
1 (25.0%)Phase 2
1 (25.0%)Prescription Medication Interactions
Phase 1
Completed
- Conditions
- Opioid UseSedative Use
- Interventions
- Drug: Opioid AgonistDrug: Sedatives
- First Posted Date
- 2020-03-19
- Last Posted Date
- 2024-06-27
- Lead Sponsor
- Sharon Walsh
- Target Recruit Count
- 11
- Registration Number
- NCT04315181
- Locations
- 🇺🇸
Center on Drug and Alcohol Research, Lexington, Kentucky, United States
Alcohol and Opioids
- First Posted Date
- 2020-03-09
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- Sharon Walsh
- Target Recruit Count
- 10
- Registration Number
- NCT04300751
- Locations
- 🇺🇸
University of Kentucky, Lexington, Kentucky, United States
Aprepitant Effects on Oxycodone Response
Not Applicable
Completed
- Conditions
- Narcotic Abuse
- Interventions
- First Posted Date
- 2009-10-21
- Last Posted Date
- 2017-09-01
- Lead Sponsor
- Sharon Walsh
- Target Recruit Count
- 9
- Registration Number
- NCT00999544
- Locations
- 🇺🇸
University of Kentucky, Lexington, Kentucky, United States
Evaluation of Atomoxetine for Cocaine Dependence: A Pilot Trial
- First Posted Date
- 2008-02-15
- Last Posted Date
- 2017-08-31
- Lead Sponsor
- Sharon Walsh
- Target Recruit Count
- 50
- Registration Number
- NCT00617201
- Locations
- 🇺🇸
Straus Research Building, Lexington, Kentucky, United States
News
No news found